Evidence map›Paper›PMID 32419947›Full record

ArticleClinical & translational immunology2020

Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination.

Johanna E Huber, Julia Ahlfeld, Magdalena K Scheck, Magdalena Zaucha, Klaus Witter, Lisa Lehmann, Hadi Karimzadeh, Michael Pritsch, Michael Hoelscher, Frank von Sonnenburg and 5 more

Open access · goldAbstract read
In one paragraph

Article in Clinical & translational immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. TIGITFrontiers in immunology · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Johanna E HuberInstitute for Immunology Biomedical Center Faculty of Medicine LMU Munich Planegg-Martinsried Germany.ORCID https://orcid.org/0000-0002-7667-4285
Julia AhlfeldDivision of Clinical Pharmacology University Hospital LMU Munich Munich Germany.ORCID https://orcid.org/0000-0002-4879-4159
Magdalena K ScheckDivision of Clinical Pharmacology University Hospital LMU Munich Munich Germany.ORCID https://orcid.org/0000-0003-3589-7535
Magdalena ZauchaDivision of Clinical Pharmacology University Hospital LMU Munich Munich Germany.ORCID https://orcid.org/0000-0002-3590-1525
Klaus WitterLaboratory of Immunogenetics and Molecular Diagnostics Department of Transfusion Medicine, Cell Therapeutic Agents and Hemostaseology LMU Munich Munich Germany.
Lisa LehmannDivision of Clinical Pharmacology University Hospital LMU Munich Munich Germany.ORCID https://orcid.org/0000-0002-5153-3371
Hadi KarimzadehDivision of Clinical Pharmacology University Hospital LMU Munich Munich Germany.ORCID https://orcid.org/0000-0003-2264-4395
Michael PritschDivision of Infectious Diseases and Tropical Medicine University Hospital LMU Munich Munich Germany.ORCID https://orcid.org/0000-0001-7383-8750
Michael HoelscherDivision of Infectious Diseases and Tropical Medicine University Hospital LMU Munich Munich Germany.
Frank von SonnenburgDivision of Infectious Diseases and Tropical Medicine University Hospital LMU Munich Munich Germany.
Andrea DickLaboratory of Immunogenetics and Molecular Diagnostics Department of Transfusion Medicine, Cell Therapeutic Agents and Hemostaseology LMU Munich Munich Germany.ORCID https://orcid.org/0000-0001-5111-6845
Giovanna Barba-SpaethStructural Virology Unit and CNRS UMR 3569 Virology Department Institut Pasteur Paris France.ORCID https://orcid.org/0000-0003-2069-9501
Anne B KrugInstitute for Immunology Biomedical Center Faculty of Medicine LMU Munich Planegg-Martinsried Germany.ORCID https://orcid.org/0000-0002-9556-7207
Simon RothenfußerDivision of Clinical Pharmacology University Hospital LMU Munich Munich Germany.ORCID https://orcid.org/0000-0003-1151-7614
Dirk BaumjohannInstitute for Immunology Biomedical Center Faculty of Medicine LMU Munich Planegg-Martinsried Germany.ORCID https://orcid.org/0000-0001-8385-8288
LMU Klinikum · DEHelmholtz Zentrum München · DELudwig-Maximilians-Universität München · DEUrologische Klinik München · DECentre National de la Recherche Scientifique · FRUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesT follicular helper (Tfh) cells are the principal T helper cell subset that provides help to B cells for potent antibody responses against various pathogens. In this study, we took advantage of the live-attenuated yellow fever virus (YFV) vaccine strain, YF-17D, as a model system for studying human antiviral immune responses

methodsWe tracked and analysed the response of cTfh and other T and B cell subsets in peripheral blood of healthy volunteers by flow cytometry over the course of 4 weeks after YF-17D vaccination.

resultsUsing surface staining of cell activation markers to track YFV-specific T cells, we found increasing cTfh cell frequencies starting at day 3 and peaking around 2 weeks after YF-17D vaccination. This kinetic was confirmed in a subgroup of donors using MHC multimer staining for four known MHC class II epitopes of YF-17D. The subset composition of cTfh cells changed dynamically during the course of the immune response and was dominated by the cTfh1-polarised subpopulation. Importantly, frequencies of cTfh1 cells correlated with the strength of the neutralising antibody response, whereas frequencies of cTfh17 cells were inversely correlated.

conclusionIn summary, we describe detailed cTfh kinetics during YF-17D vaccination. Our results suggest that cTfh expansion and polarisation can serve as a prognostic marker for vaccine success. These insights may be leveraged in the future to improve current vaccine design and strategies.

Indexed as

neutralising antibodiesT follicular helper (Tfh) cellsvaccinationviral infectionyellow feverYF‐17D

Identifiers

PMID32419947
PMCPMC7221214
OpenAlexW3024900840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.